Notice of affirmative preliminary CVD determination, affirmative critical circumstances, and alignment of the final CVD determination with the AD investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from the People's Republic of China (C-570-235)
Initiation of countervailing duty investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from the People's Republic of China (C-570-235)